Norovirus has torn through the U.S. this winter, peaking early in some parts of the country but taking hold in South Florida ...
In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it counts—in the saliva of older people most vulnerable to the explosive ...
Norovirus is also hard to kill on surfaces, where it can live for days to weeks. If someone in your household vomits in the ...
Wealthfront Advisers LLC lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 84.4% during the fourth quarter, according to the company in its most recent disclosure with the ...
This method is simpler to execute and can be more easily updated as different strains of norovirus become dominant, Fink says. His team at Moderna designed an mRNA norovirus vaccine, and the ...
HEALTH chiefs have warned winter “is certainly not over” with norovirus hospitalisations still close to record highs – and ...
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a ...
while revenue fell to $966M from $2.81B but beat the $942.8M consensus Moderna’s norovirus vaccine trial is on FDA hold due to a Guillain-Barré syndrome case but expects no impact on efficacy ...
The FDA placed a clinical hold on Moderna's norovirus vaccine trial following a case of Guillain-Barré syndrome, the company said. Contrary to expectations, low-dose non-steroidal anti ...
Moderna’s Phase 3 norovirus vaccine trial (mRNA-1403) was placed on clinical hold due to a case of Guillain-Barré syndrome (GBS). However, Barclays noted that trial timelines may remain intact ...
Moderna sports a $13 billion market cap but ... In addition to vaccines it markets now, shots to prevent flu, cytomegalovirus, and norovirus are in late-stage development. The company has already ...
There is no antiviral treatment for norovirus, and while there isn’t currently a vaccine, drug manufacturer Moderna is working on one. Any norovirus vaccine would require an educated guess as to ...